jlf101

John L. Farber, MD

Contact Dr. Farber

132 South 10th Street
Main Building, Suite 285
Philadelphia, PA 19107

(215) 503-5028
(215) 923-2218 fax

Most Recent Peer-reviewed Publications

  1. The Problem of Subclinical Antibody-mediated Rejection in Kidney Transplantation
  2. Histologic antibody-mediated kidney allograft rejection in the absence of donor-specific HLA antibodies
  3. The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation
  4. Abrogation of esophageal carcinoma development in miR-31 knockout rats
  5. The implications of B-lineage cells in kidney allografts
  6. Assessing carotid plaque neovascularity and calcifications in patients prior to endarterectomy
  7. Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats
  8. Transplant glomerulopathy
  9. The Nephrotoxicity of Vancomycin
  10. Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neopl
  11. Rapidly Fatal Hemophagocytic Lymphohistiocytosis Developing Within Six Days Following Deceased-Donor Renal Transplantation: Case Report
  12. Membranous nephropathy in the kidney allograft
  13. Hemophagocytic lymphohistiocytosis: an update for nephrologists
  14. Correlation of acute tubular injury in reperfusion biopsy with renal transplant outcomes
  15. The humoral theory of transplantation: Epitope analysis and the pathogenicity of HLA antibodies
  16. Zinc intake, microRNA dysregulation, and esophageal cancer
  17. MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency
  18. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue from Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
  19. Repression of esophageal neoplasia and inflammatory signaling by anti-MIR-31 delivery in vivo
  20. Humoral Immune Response and Allograft Function in Kidney Transplantation
  21. Humoral immunity in renal transplantation: Epitopes, Cw and DP, and complement-activating capability - an update
  22. Sensitization, pathologic, and imaging findings comparing symptomatic and quiescent failed renal allografts
  23. Posttransplantation normoglycemic diabetic nephropathy: The role of the allograft insulin resistance-a case report
  24. Venous cystic adventitial disease of the common femoral vein
  25. The specificity of acute and chronic microvascular alterations in renal allografts